Evidence map›Paper›PMID 41867238›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Novel transposon Tn

Michael B Hall, Yiyang Xue, Tricia S E Lee, Ella Herring, Jocelyn Hume, Ryan R Wick, Timothy Kidd, Naomi Runnegar, Patrick N A Harris, Bianca Graves and 1 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Michael B HallThe University of Queensland, UQ Centre for Clinical Research, Herston, QLD 4029, Australia.ORCID 0000-0003-3683-6208
Yiyang XueThe University of Queensland, UQ Centre for Clinical Research, Herston, QLD 4029, Australia.ORCID 0009-0007-8272-6591
Tricia S E LeeThe University of Queensland, UQ Centre for Clinical Research, Herston, QLD 4029, Australia.ORCID 0009-0002-8137-4938
Ella HerringThe University of Queensland, UQ Centre for Clinical Research, Herston, QLD 4029, Australia.ORCID 0000-0003-0100-4217
Jocelyn HumeThe University of Queensland, UQ Centre for Clinical Research, Herston, QLD 4029, Australia.ORCID 0000-0002-1092-4958
Ryan R WickDepartment of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Australia.ORCID 0000-0001-8349-0778
Timothy KiddCentral Microbiology, Pathology Queensland, Royal Brisbane and Women's Hospital, Herston, QLD 4029, Australia.ORCID 0000-0002-6135-6364
Naomi RunnegarInfection Management Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia.ORCID 0000-0003-1196-4131
Patrick N A HarrisThe University of Queensland, UQ Centre for Clinical Research, Herston, QLD 4029, Australia.ORCID 0000-0002-2895-0345
Bianca GravesCentral Microbiology, Pathology Queensland, Royal Brisbane and Women's Hospital, Herston, QLD 4029, Australia.ORCID 0000-0002-0634-677X
Leah W RobertsThe University of Queensland, UQ Centre for Clinical Research, Herston, QLD 4029, Australia.ORCID 0000-0002-1024-0564

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Linezolid is a critical last-resort antimicrobial for multidrug-resistant

Identifiers

PMID41867238
PMCPMC13004148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.